These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33566559)

  • 1. No Effect in Alcoholic Hepatitis of Gut-Selective, Broad-Spectrum Antibiotics on Bacterial Translocation or Hepatic and Systemic Inflammation.
    Støy S; Laursen TL; Eriksen LL; Grønbæk H; Vilstrup H; Sandahl TD
    Clin Transl Gastroenterol; 2021 Jan; 12(2):e00306. PubMed ID: 33566559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic Hepatitis.
    Saha B; Tornai D; Kodys K; Adejumo A; Lowe P; McClain C; Mitchell M; McCullough A; Dasarathy S; Kroll-Desrosiers A; Barton B; Radaeva S; Szabo G
    Hepatology; 2019 Oct; 70(4):1134-1149. PubMed ID: 30891779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
    Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Biomarkers of Intestinal Epithelium Damage Regenerating Islet-derived Protein 3α and Trefoil Factor 3 Are Persistently Elevated in Patients with Alcoholic Hepatitis.
    Yang J; Syed F; Xia Y; Sanyal AJ; Shah VH; Chalasani N; Zheng X; Yu Q; Lou Y; Li W
    Alcohol Clin Exp Res; 2021 Apr; 45(4):720-731. PubMed ID: 33587293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum bile acids profiles are altered without change of the gut microbiota composition following a seven-day prednisolone therapy in severe alcoholic hepatitis.
    Esparteiro D; Fouquet G; Courtois A; Jedraszak G; Marticho L; Gourdel M; Billon-Crossouard S; Croyal M; Naassila M; Nguyen-Khac E; Marcq I
    Gut Microbes; 2024; 16(1):2382767. PubMed ID: 39078043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
    Jørgensen SF; Macpherson ME; Bjørnetrø T; Holm K; Kummen M; Rashidi A; Michelsen AE; Lekva T; Halvorsen B; Trøseid M; Mollnes TE; Berge RK; Yndestad A; Ueland T; Karlsen TH; Aukrust P; Hov JR; Fevang B
    Sci Rep; 2019 Jan; 9(1):167. PubMed ID: 30655568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients.
    Lang S; Fairfied B; Gao B; Duan Y; Zhang X; Fouts DE; Schnabl B
    Gut Microbes; 2020 Nov; 12(1):1785251. PubMed ID: 32684075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial.
    Kimer N; Meldgaard M; Hamberg O; Kronborg TM; Lund AM; Møller HJ; Bendtsen F; Ytting H
    PLoS One; 2022; 17(3):e0264278. PubMed ID: 35286322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy.
    Canipe A; Chidumayo T; Blevins M; Bestawros M; Bala J; Kelly P; Filteau S; Shepherd BE; Heimburger DC; Koethe JR
    BMC Infect Dis; 2014 Sep; 14():521. PubMed ID: 25266928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.
    Reiberger T; Ferlitsch A; Payer BA; Mandorfer M; Heinisch BB; Hayden H; Lammert F; Trauner M; Peck-Radosavljevic M; Vogelsang H;
    J Hepatol; 2013 May; 58(5):911-21. PubMed ID: 23262249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study.
    Parker R; Im G; Jones F; Hernández OP; Nahas J; Kumar A; Wheatley D; Sinha A; Gonzalez-Reimers E; Sanchez-Pérez M; Ghezzi A; David MD; Corbett C; McCune A; Aithal GP; Holt A; Stewart S
    J Gastroenterol; 2017 Nov; 52(11):1192-1200. PubMed ID: 28389732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients.
    Villanueva-Millán MJ; Pérez-Matute P; Recio-Fernández E; Lezana Rosales JM; Oteo JA
    J Int AIDS Soc; 2017 Mar; 20(1):21526. PubMed ID: 28362071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice.
    Lowe PP; Gyongyosi B; Satishchandran A; Iracheta-Vellve A; Ambade A; Kodys K; Catalano D; Ward DV; Szabo G
    PLoS One; 2017; 12(3):e0174544. PubMed ID: 28350851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic macrophage activation and the LPS pathway in patients with alcoholic hepatitis: a prospective cohort study.
    Sandahl TD; Grønbaek H; Møller HJ; Støy S; Thomsen KL; Dige AK; Agnholt J; Hamilton-Dutoit S; Thiel S; Vilstrup H
    Am J Gastroenterol; 2014 Nov; 109(11):1749-56. PubMed ID: 25155228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary tumors alter the fecal bacteriome and permit enteric bacterial translocation.
    Loman BR; Russart KLG; Grant CV; Lynch AJ; Bailey MT; Pyter LM
    BMC Cancer; 2022 Mar; 22(1):245. PubMed ID: 35248004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Co-Trimoxazole on Microbial Translocation in HIV-1-Infected Patients Initiating Antiretroviral Therapy.
    Vesterbacka J; Barqasho B; Häggblom A; Nowak P
    AIDS Res Hum Retroviruses; 2015 Aug; 31(8):830-6. PubMed ID: 26059763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial.
    Villar-García J; Hernández JJ; Güerri-Fernández R; González A; Lerma E; Guelar A; Saenz D; Sorlí L; Montero M; Horcajada JP; Knobel Freud H
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):256-63. PubMed ID: 25469528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy: New hope for alcoholic hepatitis?
    Gao B; Shah VH
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1(Suppl 1):S7-S11. PubMed ID: 26193867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marital distress, depression, and a leaky gut: Translocation of bacterial endotoxin as a pathway to inflammation.
    Kiecolt-Glaser JK; Wilson SJ; Bailey ML; Andridge R; Peng J; Jaremka LM; Fagundes CP; Malarkey WB; Laskowski B; Belury MA
    Psychoneuroendocrinology; 2018 Dec; 98():52-60. PubMed ID: 30098513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.